EVOK logo

Evoke Pharma (EVOK) Retained Earnings

Annual Retained Earnings

-$123.44 M
-$7.79 M-6.74%

December 31, 2023


Summary


Performance

EVOK Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherEVOKbalance sheetmetrics:

Quarterly Retained Earnings

-$127.60 M
-$1.31 M-1.04%

September 30, 2024


Summary


Performance

EVOK Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherEVOKbalance sheetmetrics:

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

EVOK Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-6.7%-3.4%
3 y3 years-24.8%-6.5%
5 y5 years-57.0%-6.5%

EVOK Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-14.9%at low-18.8%at low
5 y5-year-44.0%at low-48.8%at low
alltimeall time-592.0%at low-542.6%at low

Evoke Pharma Retained Earnings History

DateAnnualQuarterly
Sep 2024
-
-$127.60 M(+1.0%)
Jun 2024
-
-$126.29 M(+1.0%)
Mar 2024
-
-$125.02 M(+1.3%)
Dec 2023
-$123.44 M(+6.7%)
-$123.44 M(+1.6%)
Sep 2023
-
-$121.45 M(+1.4%)
Jun 2023
-
-$119.76 M(+1.6%)
Mar 2023
-
-$117.89 M(+1.9%)
Dec 2022
-$115.65 M(+7.7%)
-$115.65 M(+1.6%)
Sep 2022
-
-$113.84 M(+1.8%)
Jun 2022
-
-$111.83 M(+2.0%)
Mar 2022
-
-$109.60 M(+2.0%)
Dec 2021
-$107.42 M(+8.6%)
-$107.42 M(+1.6%)
Sep 2021
-
-$105.75 M(+1.9%)
Jun 2021
-
-$103.78 M(+2.3%)
Mar 2021
-
-$101.49 M(+2.6%)
Dec 2020
-$98.89 M(+15.3%)
-$98.89 M(+2.3%)
Sep 2020
-
-$96.62 M(+2.3%)
Jun 2020
-
-$94.49 M(+8.0%)
Mar 2020
-
-$87.52 M(+2.1%)
Dec 2019
-$85.73 M(+9.1%)
-$85.73 M(+1.7%)
Sep 2019
-
-$84.31 M(+2.0%)
Jun 2019
-
-$82.68 M(+2.6%)
Mar 2019
-
-$80.57 M(+2.5%)
Dec 2018
-$78.60 M
-$78.60 M(+2.3%)
DateAnnualQuarterly
Sep 2018
-
-$76.84 M(+2.0%)
Jun 2018
-
-$75.32 M(+3.2%)
Mar 2018
-
-$73.02 M(+2.8%)
Dec 2017
-$71.04 M(+20.8%)
-$71.04 M(+0.4%)
Sep 2017
-
-$70.73 M(+8.0%)
Jun 2017
-
-$65.49 M(+2.5%)
Mar 2017
-
-$63.86 M(+8.6%)
Dec 2016
-$58.81 M(+22.4%)
-$58.81 M(+2.7%)
Sep 2016
-
-$57.28 M(+5.6%)
Jun 2016
-
-$54.26 M(+5.8%)
Mar 2016
-
-$51.29 M(+6.7%)
Dec 2015
-$48.06 M(+33.7%)
-$48.06 M(+5.8%)
Sep 2015
-
-$45.44 M(+6.4%)
Jun 2015
-
-$42.70 M(+8.2%)
Mar 2015
-
-$39.46 M(+9.8%)
Dec 2014
-$35.94 M(+58.4%)
-$35.94 M(+8.8%)
Sep 2014
-
-$33.02 M(+13.1%)
Jun 2014
-
-$29.19 M(+13.8%)
Mar 2014
-
-$25.65 M(+13.0%)
Dec 2013
-$22.69 M(+14.3%)
-$22.69 M(+7.7%)
Sep 2013
-
-$21.07 M(+2.4%)
Jun 2013
-
-$20.59 M(+1.2%)
Mar 2013
-
-$20.35 M(+2.5%)
Dec 2012
-$19.86 M(+11.3%)
-$19.86 M
Dec 2011
-$17.84 M
-

FAQ

  • What is Evoke Pharma annual retained earnings?
  • What is the all time high annual retained earnings for Evoke Pharma?
  • What is Evoke Pharma annual retained earnings year-on-year change?
  • What is Evoke Pharma quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Evoke Pharma?
  • What is Evoke Pharma quarterly retained earnings year-on-year change?

What is Evoke Pharma annual retained earnings?

The current annual retained earnings of EVOK is -$123.44 M

What is the all time high annual retained earnings for Evoke Pharma?

Evoke Pharma all-time high annual retained earnings is -$17.84 M

What is Evoke Pharma annual retained earnings year-on-year change?

Over the past year, EVOK annual retained earnings has changed by -$7.79 M (-6.74%)

What is Evoke Pharma quarterly retained earnings?

The current quarterly retained earnings of EVOK is -$127.60 M

What is the all time high quarterly retained earnings for Evoke Pharma?

Evoke Pharma all-time high quarterly retained earnings is -$19.86 M

What is Evoke Pharma quarterly retained earnings year-on-year change?

Over the past year, EVOK quarterly retained earnings has changed by -$4.16 M (-3.37%)